AKTX
Akari Therapeutics
AKTX
AKTX
13 hedge funds and large institutions have $15.1M invested in Akari Therapeutics in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$561K | |
| 2 | +$80K | |
| 3 | +$52.6K | |
| 4 |
HNB
Huntington National Bank
Columbus,
Ohio
|
+$49K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$23.5K |
Top Sellers
| 1 | -$2.36M | |
| 2 | -$1.12M | |
| 3 | -$605K | |
| 4 |
QF
QVT Financial
New York
|
-$531K |
| 5 |
JPMorgan Chase & Co
New York
|
-$11K |